微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Fulcrum Therapeutics (NASDAQ:FULC) +125%
Exagen (NASDAQ:XGN) +24%
Myomo (NYSE:MYO) +16%
IMV (NASDAQ:IMV) +8%
Allied Healthcare Products (NASDAQ:AHPI) +6%
Losers:...查看全文
格隆汇3月14日丨Myomo(MYO.US)盘前继续上涨8.44%,报0.835美元,该股月内累计涨幅近20%,且昨日涨4%创阶段新高。公司2022年Q4财报实现营收404.2万美元,前值为403.2万美元,预期值为406万美元;每... 网页链接
$Myomo(MYO)$ 8-K - Current report Filed: 2019-03-07 AccNo: 0001193125-19-067201 Size: 154 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Myomo(MYO)$ 美东时间 2019-03-07 盘后 披露财报,预期EPS -0.23 网页链接
$Myomo(MYO)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2019-02-08 AccNo: 0001193125-19-032461 Size: 784 KB 网页链接
$Myomo(MYO)$ 8-K - Current report Filed: 2019-02-08 AccNo: 0001193125-19-031643 Size: 352 KBItem 1.01: Entry into a Material Definitive AgreementItem 3.02: Unregistered Sales of Equity SecuritiesItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Myomo(MYO)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2019-02-07 AccNo: 0001193125-19-030869 Size: 16 KB 网页链接
$Myomo(MYO)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2019-02-07 AccNo: 0001193125-19-030874 Size: 789 KB 网页链接
$Myomo(MYO)$ 8-K - Current report Filed: 2019-02-07 AccNo: 0001193125-19-030883 Size: 19 KBItem 2.02: Results of Operations and Financial Condition 网页链接
$Myomo(MYO)$ 8-K - Current report Filed: 2019-02-06 AccNo: 0001193125-19-028892 Size: 134 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 7.01: Regulation FD Dis...
$Myomo Inc.(MYO)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-11-07 AccNo: 0001564590-18-027998 Size: 4 MB 网页链接
$Myomo Inc.(MYO)$ 8-K - Current report Filed: 2018-11-05 AccNo: 0001193125-18-318391 Size: 161 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接